0 140

Cited 9 times in

Prognostic value of pretreatment FDG PET in pediatric neuroblastoma

Authors
 Jeong Won Lee  ;  Arthur Cho  ;  Mijin Yun  ;  Jong Doo Lee  ;  Chuhl Joo Lyu  ;  Won Jun Kang 
Citation
 European Journal of Radiology, Vol.84(12) : 2633-2639, 2015 
Journal Title
 European Journal of Radiology 
ISSN
 0720-048X 
Issue Date
2015
MeSH
Child, Preschool ; Disease Progression ; Disease-Free Survival ; Female ; Fluorodeoxyglucose F18* ; Follow-Up Studies ; Humans ; Male ; Neuroblastoma/diagnostic imaging* ; Positron-Emission Tomography* ; Prognosis ; Radiopharmaceuticals* ; Retrospective Studies ; Survival Rate
Keywords
(18)F-fluorodeoxyglucose ; Neuroblastoma ; Positron emission tomography ; Prognosis
Abstract
PURPOSE: This study aimed to evaluate the prognostic value of pretreatment (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in pediatric neuroblastoma patients. METHODS: The study included 50 pediatric neuroblastoma patients who underwent diagnostic work-up FDG PET before any treatment. The maximum standardized uptake value (SUV(max)) of the primary tumor lesion (P(max)), the SUV(max) of all the tumor lesions, including the primary tumor lesion and metastatic lesions (T(max)), and the uptake ratio of T(max) to mean SUV of normal liver tissue (T(max)/L(mean)) were calculated and tested as prognostic factors. RESULTS: Of the 50 patients, 15 (30.0%) experienced disease progression and 21 (42.0%) died during the follow-up period. On univariate analysis, the histopathology, tumor stage, bone marrow involvement, serum levels of lactate dehydrogenase (LDH), neuron-specific enolase, and ferritin, primary tumor size, P(max), T(max), and T(max)/L(mean) were significant prognostic factors for disease progression-free survival (PFS), whereas the tumor stage, serum level of LDH, T(max), and T(max)/L(mean) were determined to be significant for predicting overall survival (OS). On multivariate analysis, the histopathology and serum level of LDH were independent prognostic factors for PFS, and only the T(max)/L(mean) was an independent prognostic factor for OS. The 2-year PFS and OS rates were over 80.0% in patients with low FDG uptake, meanwhile, patients with high FDG uptake showed the 2-year PFS of less than 30.0% and OS of less than 55.0%. CONCLUSION: FDG PET was an independent prognostic factor for OS in neuroblastoma patients. FDG PET can provide effective information on the prognosis for neuroblastoma patients.
Full Text
https://www.sciencedirect.com/science/article/pii/S0720048X15301182
DOI
10.1016/j.ejrad.2015.09.027
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Won Jun(강원준) ORCID logo https://orcid.org/0000-0002-2107-8160
Lyu, Chuhl Joo(유철주) ORCID logo https://orcid.org/0000-0001-7124-7818
Yun, Mi Jin(윤미진) ORCID logo https://orcid.org/0000-0002-1712-163X
Cho, Arthur Eung Hyuck(조응혁) ORCID logo https://orcid.org/0000-0001-8670-2473
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/156988
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse